Changes to Russian e-cigarette regulations questioned

Apr.18.2023
Changes to Russian e-cigarette regulations questioned
CRPT, the operator of the "honest label" system, confirms no changes to their system due to e-cigarette additives ban in Russia.

On April 17th, in response to the "ban on e-cigarette additives," 2FIRSTS Moscow News Center interviewed Yuri Babinkov, the manager of the tobacco department of the "Honest Label" operation company, about the potential impact of changes to related regulatory legislation on the existing "Honest Label" system.


Yuri Babinkov | Image Source: 2FIRSTS


According to Yuri Babinkov, the manager of the tobacco department at the CRPT, ...


There will be no changes to the "honest labeling" requirements, as electronic cigarettes will be subject to mandatory labeling restrictions.


However, he stated that due to the fact that ЦРПТ company is affiliated with the state, he is unable to answer any further questions regarding trade.


According to reports, CRPT Company is the fully authorized operator of the "Honest Label" system in Russia, and is a state-owned enterprise of the Russian Federation. On November 30, 2022, the revised version of the Russian Federation's Product Circulation Control Act No. 2178 will come into effect, which mandates the use of a tracking system for "tobacco and nicotine-containing products, as well as nicotine-free products." Failure to operate such products with traceability labels will result in penalties under the Russian Federation's Administrative Violations Code and Criminal Code, depending on the severity of the offense.


Honest Label" is a Russian product tracking system that currently covers more than a dozen categories, including tobacco, food, drugs, tires, and textiles. The system was launched in 2018 and has been effective in regulating product quality. On December 15th, 2022, e-cigarettes containing nicotine oil were included in the "Honest Label" regulation.


Related Reading:


Russian nicotine product producers must apply for a license" - This bill has passed its first reading.


In One Day, Russian Flavor Ban Timeline and Background Sketch Passes Three Readings Through Bill


Russian Ban on E-Cigarette Flavorings to Take Effect on September 1; Full Proposal Attached. On April 11, Russia Will Hold First Discussion on Proposal to Ban Flavored E-Cigarettes.


Russia proposes a maximum fine of 500,000 rubles for selling electronic cigarettes to minors.


What is the progress of the ban on certain flavors in Russia's legislative process? Here is an overview of the legislative process in Russia.


Interview with Russian producer of nicotine products: The trend towards regulatory compliance is irreversible, and a complete ban on e-cigarettes is unlikely.


Expert Analysis Series:


Expert interpretation 1: Russia's ban on flavored e-cigarettes extends to all products, and specific standards for additives are yet to be disclosed.


Expert Analysis 2: Russia Sets Minimum Retail Price for E-Cigarette Products to Reduce Demand for Nicotine-Based Products.


Expert interpretation 3: Russia proposes to ban the online sale and offline display of electronic cigarettes, effective June 1.


Topic: Progress and Expert Analysis on Russia's Ban on E-Cigarette Flavors (click the image below to go to the article)



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia's new retail tobacco permit system took effect October 1, requiring sellers of vapes, nicotine products and related devices and accessories to obtain a Retail Tobacco Permit for each business location. Virginia ABC said more than 3,000 businesses applied in September alone, creating a processing backlog. Qualifying applicants that filed before October 1 may temporarily operate under a Letter of Authorization. The new store-level permit also sits alongside Virginia's existing vape product directory, where sales of unlisted liquid nicotine or nicotine vapor products can trigger civil penalties starting at $5,000.
Regulations
Oct.03
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Philip Morris Japan (PMJ) has expanded the ZYN by IQOS oral tobacco pouch portfolio in Japan with four new ZYN Strong products, adding a third intensity level alongside the existing Low and Medium ranges. The Strong series first entered selected duty-free channels in Japan on July 1, 2026, before expanding to IQOS stores, the ZYN Online Store and selected tobacco retailers from August 18. The expansion increases the Japanese ZYN by IQOS lineup from eight to 12 products.
Aug.20
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22